(E)-3-(6-Bromopyridin-2-yl)-2-cyano-N-(1-(4-(2-(diethylamino)ethoxy)phenyl)butyl)acrylamide → (E)-(2-(2-(2-(4-(1-(3-(6-Bromopyridin-2-yl)-2-cyanoacrylamido)butyl)phenoxy)ethoxy)ethoxy)ethyl)imidodicarbonic acid, 1,3-bis-tert-butyl ester
Reaction equation
[Br:1][C:2]1[N:7]=[C:6](/[CH:8]=C(\C#N)/C(NC(C2C=CC(OCCN(CC)CC)=CC=2)CCC)=O)[CH:5]=[CH:4][CH:3]=1.[C:33]([CH2:35][C:36]([NH:38][CH:39]([C:43]1[CH:72]=[CH:71][C:46]([O:47][CH2:48][CH2:49][O:50][CH2:51][CH2:52][O:53][CH2:54][CH2:55][N:56]([C:64]([O:66][C:67]([CH3:70])([CH3:69])[CH3:68])=[O:65])[C:57]([O:59][C:60]([CH3:63])([CH3:62])[CH3:61])=[O:58])=[CH:45][CH:44]=1)[CH2:40][CH2:41][CH3:42])=[O:37])#[N:34]>>[Br:1][C:2]1[N:7]=[C:6](/[CH:8]=[C:35](\[C:33]#[N:34])/[C:36]([NH:38][CH:39]([C:43]2[CH:72]=[CH:71][C:46]([O:47][CH2:48][CH2:49][O:50][CH2:51][CH2:52][O:53][CH2:54][CH2:55][N:56]([C:57]([O:59][C:60]([CH3:62])([CH3:63])[CH3:61])=[O:58])[C:64]([O:66][C:67]([CH3:70])([CH3:69])[CH3:68])=[O:65])=[CH:45][CH:44]=2)[CH2:40][CH2:41][CH3:42])=[O:37])[CH:5]=[CH:4][CH:3]=1Participants
3
Reactant 2
Product 1
Procedure
The title compound was prepared by using a similar procedure as described for the preparation of 33 except that (2-(2-(2-(4-(1-(2-cyanoacetamido)butyl)phenoxy)ethoxy)ethoxy)ethyl)imidodicarbonic acid, 1,3-bis-tert-butyl ester (46) was used instead of 2-cyano-N-(1-(4-(2-(diethylamino)ethoxy)phenyl)butyl)acetamide (29). This produced the crude product which was purified by flash silica gel column chromatography, eluting with 7:3 hexanes/ethyl acetate, to give 47 (105 mg, 85%) as a clear oil: MS (ES+) m/z 731.2 (M+H)+.
Workup
- customThis produced the crude product which
Sources & evidence
- ORD record
- ord-edcaea63676b4c9489dcfe974885ce96
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08809377B2
Reaction notes
Loading…